The Biotechnology Core for the CCCR will be housed in the University of South Carolina Instrumentation Resource Facility (IRF). The IRF is an established biotechnology core, with a 20 year history, that provides a wide range of state-of-the-art equipment for microscopy, cell sorting, small animal imaging, and several molecular techniques for researchers. The facility is staffed with three full time faculty, two part time faculty, and four technicians that assist investigators with design of their experiments and grant proposals, processing of research samples, operation of equipment, and training of faculty, staff and students. Several nationally recognized workshops and graduate level courses are also available through the IRF. Funding of the IRF is generated from a variety of sources including grants from NIH for acquisition of major equipment, faculty collaborations on a variety of funding programs from federal and private sources, user fees, and University support. The goals of the Biotechnology Core will be addressed through three Specific Aims: 1) to provide access to a wide range of techniques and major equipment including, but not limited to, flow cytometry and cell sorting, histology, immunohistochemistry, live cell and confocal imaging, electron microscopy, and small animal ultrasound and fluorescence imaging;2) to provide the technical expertise to assist and train CCCR Investigators and members of their laboratories on the use of equipment available in the Biotechnology Core;and 3) through group meetings and consultation identify and prepare proposals to acquire new technology which will benefit the research programs of the CCCR and other investigators.
To fully understand the complex cell and tissue interactions that occur in cancer it is essential to have a range of instrumentation available to study the development and progression of the disease. The Biotechnology Core will provide these instruments for the CCCR and other investigators at the University of South Carolina as well as surrounding institutions.
|Farmaki, E; Chatzistamou, I; Kaza, V et al. (2016) A CCL8 gradient drives breast cancer cell dissemination. Oncogene 35:6309-6318|
|PeÃ±a, Edsel A; Wu, Wensong; Piegorsch, Walter et al. (2016) Model Selection and Estimation with Quantal-Response Data in Benchmark Risk Assessment. Risk Anal :|
|Kindo, Bereket P; Wang, Hao; PeÃ±a, Edsel A (2016) Multinomial probit Bayesian additive regression trees. Stat (Int Stat Inst) 5:119-131|
|Wallace, Kristin; Brandt, Heather M; Bearden, James D et al. (2016) Race and Prevalence of Large Bowel Polyps Among the Low-Income and Uninsured in South Carolina. Dig Dis Sci 61:265-72|
|Watson, Shana R; Liu, Piaomu; PeÃ±a, Edsel A et al. (2016) Comparison of Aortic Collagen Fiber Angle Distribution in Mouse Models of Atherosclerosis Using Second-Harmonic Generation (SHG) Microscopy. Microsc Microanal 22:55-62|
|Jung, Joo-Yong; Gleave Parson, Madeline; Kraft, Jennifer D et al. (2016) Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner. Immunology 149:35-47|
|Patel, Yogin; Shah, Nirav; Lee, Ji Shin et al. (2016) A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth. Oncotarget 7:18295-308|
|Chatzistamou, Ioulia; Kiaris, Hippokratis (2016) Modeling estrogen receptor-positive breast cancers in mice: is it the best we can do? Endocr Relat Cancer 23:C9-C12|
|Broude, Eugenia V; GyÅ‘rffy, BalÃ¡zs; Chumanevich, Alexander A et al. (2015) Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer. Curr Cancer Drug Targets 15:739-49|
|Levina, Elina; Ji, Hao; Chen, Mengqiang et al. (2015) Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells. Oncotarget 6:13088-104|
Showing the most recent 10 out of 20 publications